awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36082501-1A92A0E8-E36B-4FF9-ADA6-F37B15A7FD30
Q36082501-1A92A0E8-E36B-4FF9-ADA6-F37B15A7FD30
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36082501-1A92A0E8-E36B-4FF9-ADA6-F37B15A7FD30
A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma.
P2860
Q36082501-1A92A0E8-E36B-4FF9-ADA6-F37B15A7FD30
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36082501-1A92A0E8-E36B-4FF9-ADA6-F37B15A7FD30
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9684324cae3e7c5c1660c31c657b1083fe154675
P2860
FLAIR-only progression in bevacizumab-treated relapsing glioblastoma does not predict short survival.